LYMPHATIC TRANSPORT OF LIPOSOME-ENCAPSULATED DRUGS FOLLOWING INTRAPERITONEAL ADMINISTRATION - EFFECT OF LIPID-COMPOSITION

被引：29

作者：

HIRANO, K

HUNT, CA

STRUBBE, A

MACGREGOR, RD

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143

[2] SHIONOGI & CO LTD,SHIONOGI RES LABS,FUKUSH MA KU,OSAKA 553,JAPAN

来源：

PHARMACEUTICAL RESEARCH | 1985年 / 06期

关键词：

D O I：

10.1023/A:1016337500364

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：271 / 278

页数：8

共 26 条

[1]

ALLEN TM, 1983, J PHARMACOL EXP THER, V226, P539

[2]

BARTLETT GR, 1959, J BIOL CHEM, V234, P466

[3] LIPOSOME DIALYSIS FOR IMPROVED SIZE DISTRIBUTIONS [J].

BOSWORTH, ME ;

HUNT, CA ;

PRATT, D .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (07) :806-812

[4]

DEDRICK RL, 1978, CANCER TREAT REP, V62, P1

[5] PERITONEAL LYMPHATIC UPTAKE OF FIBRINOGEN AND ERYTHROCYTES IN THE RAT [J].

FLESSNER, MF ;

PARKER, RJ ;

SIEBER, SM .

AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (01) :H89-H96

[6]

HIRANO K, 1983, 35TH NAT M AC PHARM, V13, P135

[7] LIPOSOMES DISPOSITION INVIVO .5. LIPOSOME STABILITY IN PLASMA AND IMPLICATIONS FOR DRUG CARRIER FUNCTION [J].

HUNT, CA .

BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 719 (03) :450-463

[8]

HUNT CA, 1983, TOPICS PHARM SCI, P257

[9]

JACKSON AJ, 1981, DRUG METAB DISPOS, V9, P535

[10]

KALEDIN VI, 1981, J NATL CANCER I, V66, P881

← 1 2 3 →